HIV reservoir research examines how the virus remains in the body despite effective antiretroviral treatment. These reservoirs contain infected cells that can preserve HIV genetic material in a dormant state. Understanding viral persistence is important for investigating why current treatments cannot completely eliminate HIV. Researchers study cellular mechanisms, immune responses, viral latency, and potential approaches to reducing or eliminating persistent.
HIV reservoir research is an important area of biomedical science focused on understanding why HIV remains in the human body even when antiretroviral therapy successfully suppresses viral replication. Although modern treatments can reduce HIV levels to undetectable levels in the blood, small populations of infected cells can continue carrying viral genetic material. These persistent reservoirs create challenges for researchers studying long-term remission and potential approaches to HIV eradication.
HIV reservoirs are populations of cells that contain HIV genetic material and can preserve the virus during antiretroviral treatment. One of the most significant reservoirs involves resting memory CD4 T cells, which can carry integrated HIV DNA without actively producing new viral particles.
When HIV enters a susceptible immune cell, it converts its RNA into DNA and integrates this genetic material into the host cell's genome. In some infected cells, the viral DNA becomes transcriptionally inactive. This condition is known as latency.
Latently infected cells can remain in the body for extended periods. Because these cells do not actively produce substantial quantities of virus, they are difficult for the immune system and existing treatments to eliminate.
Several biological processes contribute to reservoir formation and maintenance:
Viral integration: HIV inserts its genetic material into the DNA of infected host cells.
Cellular latency: Viral genes become inactive, allowing infected cells to remain undetected.
Immune cell longevity: Long-lived memory T cells can preserve integrated HIV DNA.
Clonal expansion: Infected cells can multiply, producing additional cells carrying the same viral genetic material.
Tissue distribution: HIV reservoirs can exist in different anatomical locations, including lymphoid tissues and the central nervous system.
Understanding these processes helps researchers investigate why viral persistence continues even when treatment effectively controls HIV replication.
Scientists use different laboratory techniques to investigate the size, location, activity, and characteristics of HIV reservoirs. These methods help distinguish between cells carrying viral genetic material and cells capable of producing infectious virus.
One important research approach is measuring the HIV DNA present in infected cells. However, detecting viral DNA does not automatically establish that the virus is intact or capable of producing infectious particles. Researchers therefore combine genetic measurements with functional laboratory tests.
Common research methods include:
Quantitative PCR: Measures specific HIV genetic sequences in biological samples.
Digital droplet PCR: Provides sensitive measurements of HIV DNA and RNA.
Quantitative viral outgrowth assays: Estimates the frequency of cells containing replication-competent HIV.
Single-cell sequencing: Examines viral genetic material and cellular characteristics at individual-cell resolution.
Integration site analysis: Investigates where HIV DNA is inserted into host-cell chromosomes.
Tissue-based investigations: Examine potential reservoirs in lymph nodes, the gut, and other anatomical locations.
Researchers also investigate latency reversal approaches, sometimes described as shock and kill strategies. These approaches attempt to activate dormant HIV in infected cells so that the infected cells can potentially be recognized and eliminated. Other research explores strategies designed to keep HIV permanently inactive, known as block and lock approaches.
These methods remain areas of scientific investigation. No current strategy has established a widely available cure that reliably eliminates HIV reservoirs. Antiretroviral therapy remains essential for controlling HIV, and treatment interruption can allow viral replication to return.